Board of Directors

Matthew Gilbert
Green Door Capital

Matt Gilbert is a Founder and Principal with Green Door Capital Investments, LLC, a Chicago based real estate investment firm. Matt has a 20-year background in commercial real estate investment and finance, with transactional experience exceeding $2.5 billion. He has been on both the principal and advisory side of the real estate business, and has particular experience in understanding non-investment grade lease transactions involving industrial, retail and office properties.


Matt holds a Bachelor of Science degree in finance and economics from Indiana University. He is also a licensed real estate broker in the State of Illinois. Matt lives in Chicago with his wife, Meg, and two sons, Henry and Mick. Matt has been involved with the NKFI since 2004, serving on the board since 2011.

I love the NKFI’s mission: to help those affected by kidney disease through prevention, education and empowerment. Those are powerful, measurable and meaningful goals to which I know I can contribute as a board member.  I have much admiration for the passion of the NKFI staff, who work hard every day towards those same goals. I’m extremely proud to be a small part of this team that is not only helping to improve lives, but we are also helping to save lives. 

Mark L. Schwartz

Morgan Stanley
Vice President

Mark is originally from Lincolnwood, IL. He attended Tulane University, earning a Bachelor’s degree in Political Science. He currently serves on the advisory board of the Tulane University College of Liberal Arts. He earned a J.D. from the DePaul University College of Law.

Mark is Managing Director at Morgan Stanley Wealth Management. He currently resides in Highland Park, IL with his wife of 33 years, Judy. He has two grown children, Matthew and Meredith, one grandson, Avi and one granddaughter, Chloe. Mark has served on the NKFI board since 2005, including a term as president from 2010-13.

Rich Ceffalio
Wells Fargo Advisors

Rich has spent more than twenty years in the financial services industry, and he enjoys helping his clients plan the next chapter in their lives. Rich grew up in Chicago, Illinois. After attending Notre Dame High School in Niles, he furthered his formal education at DePaul University, where he majored in Finance and had a minor in Economics.

Wells Fargo Advisors is a trade name used by Wells Fargo Clearing Services, LLC, member SIPC.

Jill M. Schaaf

Jill Schaaf most recently served as president of Baxter's renal business. In this role, she led the company's global commercial organization serving renal patients and clinicians around the world. She also was global franchise head for Baxter's chronic renal franchise. Schaaf joined the company in 2001 and held several positions of increasing responsibility, all in the renal business. Among them, she served as vice president of home therapies marketing, vice president of home hemodialysis and general manager of the U.S. renal business. Prior to joining Baxter, she served in a variety of global and US marketing roles at Searle.

She served on the steering committee for Baxter’s African American Leadership Council and is the executive sponsor of Baxter Women Leaders, business resource groups for employees that provide forums for developing skills, experiencing valuable cultural connections and supporting key business initiatives. Schaaf was the chair of BAXPAC, Baxter’s political action committee. She is also on the board of directors for the American Red Cross Greater Chicago. She earned her master's degree in business administration from Washington University and has a bachelor's degree in psychology from the University of Notre Dame.

Tipu Puri, MD, PhD
University of Chicago Medicine
Chair, Professional Advisory Board

Dr. Tipu Puri is a member of the Nephrology Faculty at The University of Chicago with clinical interests in general nephrology and a particular focus on management and slowing progression of chronic kidney disease (CKD). He came to the University of Chicago Internal Medicine Residency Program in 1999 after completing his M.D. and Ph.D. degrees at Northwestern University. After completing his residency training he stayed at the University of Chicago for fellowship training in Nephrology from 2002-2004 and was subsequently recruited to the faculty in 2004. His prior research efforts focused on using a functional murine model of CKD to investigate susceptibility to development and progression of CKD. This work was supported by a National Kidney Foundation of Illinois Young Investigator Award in 2006 to Dr. Puri. His clinical activities include direct care of patients with kidney disease in in ambulatory and inpatient settings, including the intensive care unit, to patients with kidney diseases such as acute kidney injury, disorders of volume, electrolytes, or acid-base status, and end-stage renal disease (ESRD).

Dr. Puri has a strong commitment to the recruitment, education, and mentorship of future generations of physicians.  He  and serves as a medical student Career Advisor for the Pritzker School of Medicine and served as fellowship Training Program Director. He feels strongly that the most effective patient care combines a high level of competence with compassion and communication skills. His goal is to be this kind of clinician for his patients and for his mentees. As a physician-leader in University of Chicago Medicine (UCM) Dr. Puri also serves as a point of contact and resource for providers, nursing leadership, nursing, and allied health for inpatient medical care issues and to develop and engage in initiatives focused on Quality Improvement (QI) and Clinical Effectiveness (CE) in the care of hospitalized patients.  His current efforts also include work on developing a program that targets highly complex patients, such as patients with end-stage renal disease (ESRD), to deliver more effective care, improve patient outcomes, and reduce hospital (re)admissions. Dr. Puri enjoys participating in NKFI community health screenings, collaborating on Professional Advisory Board activities such as organizing the annual Controversies in Nephrology Fellowship debate and working with the NKFI staff and Board to improve existing programs and develop new programs to raise awareness of kidney disease.

For many people kidney disease is silent until it has reached advanced stages.  When I meet these people that are faced with thinking about a future of dialysis or a kidney transplant I can’t help but ask myself whether things would be different if they knew about the problem 3 years ago? 5 years ago? 10 years ago?  Making changes in lifestyle like diet and exercise is hard…managing diabetes and high blood pressure is hard…but being made aware of kidney disease when there is still time to do something about it…hopefully avoid dialysis or the need for a transplant…I would hope that might be empowering and would help people with the hard choices needed to take control of their health and take care of their kidneys.  This is a major goal of the NKFI education and screening programs and one of the most rewarding parts of my involvement.

Akash Ahuja, MD, Southwest Nephrology Associates
Andrew J. Aronson, MD, MBA, MPH
Gavin Campbell, Baxter International Inc.
Maggie Coleman, Jones Lang LaSalle
Jim Easterbrook, Fresenius Kidney Care
Tina Eddy, RN Fresenius Kidney Care
William E. Johnson, LCSW, NSW-C
Tara Goff Kamradt, Benesch, Friedlander, Coplan & Aronoff LLP
Elizabeth Lively, Gift of Hope Organ & Tissue Donor Network
Amit Mehta, Paul Hastings
Brian O'Dea, Nephrology Associates of Northern Illinois & Indiana
Melissa Prest, MS, RDN, CSR, LDN, Fresenius Medical Care
Kareen Simpson, MD, Associates in Nephrology
Susan V. Sullivan, Mercer
Frank Veach
Melissa Vester, RN, BSN, CNN, ZS Pharma, Inc.

Lifetime Trustees

Darlene & Carl Chaleff
Sandy Kagan-Angell
Rosann & Richard Noel
Alyta & Ronald Ian Reicin
Marlene Nortman Rubenstein